Active ingredient
Thiotepa
19 finished FDA listings contain Thiotepa as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- THIOTEPA
- Dosage forms
- Injection, Injection, Powder, For Solution, Injection, Powder, Lyophilized, For Solution
- Routes
- Intracavitary, Intravenous, Intravesical
- Manufacturers / labelers
- 9
- Strengths listed
- 10 mg/ml · 100 mg/1 · 15 mg/1 · 15 mg/1.5ml · 200 mg/1 · 400 mg/1
- Brand names in FDA listings
- Tepadina, Tepylute
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 10473
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 075547 | WEST-WARD PHARMS INT | 2001-04-02 | 2 |
| NDA 208264 | ADIENNE SA | 2017-01-26 | 4 |
| ANDA 210337 | DR REDDYS | 2018-05-04 | 1 |
| ANDA 209150 | HENGRUI PHARMA | 2018-05-04 | 1 |
| ANDA 213049 | MSN | 2020-03-04 | 2 |
| ANDA 214222 | GLAND | 2021-03-08 | 4 |
| ANDA 211755 | HIKMA | 2023-09-05 | 1 |
| ANDA 216037 | MEITHEAL | 2023-12-26 | 2 |
| NDA 216984 | SHORLA | 2024-06-25 | 2 |
Official labeling on DailyMed
- TEPADINA (THIOTEPA) INJECTION, POWDER, FOR SOLUTION TEPADINA (THIOTEPA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AMNEAL PHARMACEUTICALS LLC] · version 30 · 2026-02-16
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GLAND PHARMA LIMITED] · version 7 · 2026-01-26
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] · version 4 · 2025-11-17
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NOVADOZ PHARMACEUTICALS LLC] · version 2 · 2025-04-21
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [DR.REDDY'S LABORATORIES INC.,] · version 7 · 2024-08-02
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [DR.REDDY'S LABORATORIES INC.,] · version 2 · 2024-06-27
- THIOTEPA INJECTION, POWDER, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC] · version 4 · 2023-12-29
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.] · version 3 · 2023-09-29
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.] · version 4 · 2023-05-25
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] · version 1 · 2022-04-11
- THIOTEPA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.] · version 6 · 2021-11-22
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.